Compass Biotechnologies, Inc. Share Price Other OTC
Equities
US20452Q1031
Pharmaceuticals
Sales 2018 | - | Sales 2019 | - | Capitalization | 158K 12.42M |
---|---|---|---|---|---|
Net income 2018 | - 0 | Net income 2019 | - 0 | EV / Sales 2018 | - |
Net Debt 2018 | 516K 40.66M | Net Debt 2019 | 480K 37.86M | EV / Sales 2019 | - |
P/E ratio 2018 |
-2.59
x | P/E ratio 2019 |
-3.95
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 99% |
Managers | Title | Age | Since |
---|---|---|---|
Nicole Birch
CEO | Chief Executive Officer | - | 17/04/20 |
Mathew Knowles
SAM | Sales & Marketing | - | 21/07/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nicole Birch
CEO | Chief Executive Officer | - | 17/04/20 |
1st Jan change | Capi. | |
---|---|---|
+45.15% | 6.34B | |
-14.00% | 4.61B | |
+9.54% | 3.39B | |
-8.99% | 3.29B | |
+50.03% | 2.02B | |
-6.97% | 1.73B | |
-0.31% | 1.67B | |
+50.00% | 1.63B | |
-10.61% | 1.59B |